332 related articles for article (PubMed ID: 36999009)
21. Multi-Omics Analysis Reveals Intratumor Microbes as Immunomodulators in Colorectal Cancer.
Liu Z; Zhang X; Zhang H; Zhang H; Yi Z; Zhang Q; Liu Q; Liu X
Microbiol Spectr; 2023 Feb; 11(2):e0503822. PubMed ID: 36786568
[TBL] [Abstract][Full Text] [Related]
22. Micronutrients impact the gut microbiota and blood glucose.
Barra NG; Anhê FF; Cavallari JF; Singh AM; Chan DY; Schertzer JD
J Endocrinol; 2021 Jul; 250(2):R1-R21. PubMed ID: 34165440
[TBL] [Abstract][Full Text] [Related]
23. Quantitative microbiome profiling links gut community variation to microbial load.
Vandeputte D; Kathagen G; D'hoe K; Vieira-Silva S; Valles-Colomer M; Sabino J; Wang J; Tito RY; De Commer L; Darzi Y; Vermeire S; Falony G; Raes J
Nature; 2017 Nov; 551(7681):507-511. PubMed ID: 29143816
[TBL] [Abstract][Full Text] [Related]
24. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.
Parida S; Sharma D
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):392-405. PubMed ID: 30981803
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiome and adaptive immunity in schizophrenia.
Agorastos A; Bozikas VP
Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
[TBL] [Abstract][Full Text] [Related]
26. Novel Inter-omic Analysis Reveals Relationships Between Diverse Gut Microbiota and Host Immune Dysregulation in HLA-B27-Induced Experimental Spondyloarthritis.
Gill T; Brooks SR; Rosenbaum JT; Asquith M; Colbert RA
Arthritis Rheumatol; 2019 Nov; 71(11):1849-1857. PubMed ID: 31216122
[TBL] [Abstract][Full Text] [Related]
27. Understanding the host-microbe interactions using metabolic modeling.
Jansma J; El Aidy S
Microbiome; 2021 Jan; 9(1):16. PubMed ID: 33472685
[TBL] [Abstract][Full Text] [Related]
28. Cancer Microbiome; Opportunities and Challenges.
Nallanchakravarthula S; Amruta N; Ramamurthy C
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):215-229. PubMed ID: 32819239
[TBL] [Abstract][Full Text] [Related]
29. Gene variations in autism spectrum disorder are associated with alteration of gut microbiota, metabolites and cytokines.
Liu Z; Mao X; Dan Z; Pei Y; Xu R; Guo M; Liu K; Zhang F; Chen J; Su C; Zhuang Y; Tang J; Xia Y; Qin L; Hu Z; Liu X
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33412999
[TBL] [Abstract][Full Text] [Related]
30. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients.
Mao AW; Barck H; Young J; Paley A; Mao J-; Chang H
Clin Transl Oncol; 2022 Mar; 24(3):597-604. PubMed ID: 34741726
[TBL] [Abstract][Full Text] [Related]
32. AMON: annotation of metabolite origins via networks to integrate microbiome and metabolome data.
Shaffer M; Thurimella K; Quinn K; Doenges K; Zhang X; Bokatzian S; Reisdorph N; Lozupone CA
BMC Bioinformatics; 2019 Nov; 20(1):614. PubMed ID: 31779604
[TBL] [Abstract][Full Text] [Related]
33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
34. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
35. The Microbiome as a Component of the Tumor Microenvironment.
Kovács T; Mikó E; Ujlaki G; Sári Z; Bai P
Adv Exp Med Biol; 2020; 1225():137-153. PubMed ID: 32030653
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of intratumor microbiome in head and neck squamous cell carcinoma.
Wang Y; Wang Y; Wang J
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4127-4136. PubMed ID: 35122129
[TBL] [Abstract][Full Text] [Related]
37. The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.
Du Z; Wang J; Lu Y; Ma X; Wen R; Lin J; Zhou C; Song Z; Li J; Tu P; Jiang Y
Phytomedicine; 2020 Dec; 79():153322. PubMed ID: 32920286
[TBL] [Abstract][Full Text] [Related]
38. Manipulation of gut microbiota during critical developmental windows affects host physiological performance and disease susceptibility across ontogeny.
Warne RW; Kirschman L; Zeglin L
J Anim Ecol; 2019 Jun; 88(6):845-856. PubMed ID: 30828805
[TBL] [Abstract][Full Text] [Related]
39. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
40. Intratumor microbiota: a novel tumor component.
Gong Y; Huang X; Wang M; Liang X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6675-6691. PubMed ID: 36639531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]